blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2004156

EP2004156 - COMPOSITIONS FOR TRANSFECTION OF OLIGONUCLEOTIDES ACTIVE FOR GENE SILENCING AND THEIR BIOLOGICAL AND THERAPEUTICAL APPLICATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.12.2011
Database last updated on 03.09.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Polyplus-Transfection SA
Boulevard Sébastien Brandt Bioparc BP 90018
67401 Illkirch Cedex / FR
[2008/52]
Inventor(s)01 / NEUBERG, Patrick
25, rue Vincent Scotto
67400 Illkirch / FR
02 / BOLCATO BELLEMIN, Anne-Laure
39, Rue du Markstein
67100 Strasbourg / FR
03 / BEHR, Jean-Paul
7, rue Eugénie
67100 Strasbourg / FR
04 / ERBACHER, Patrick
6, Rue Pont Neuf
67230 Benfeld / FR
 [2008/52]
Representative(s)Peaucelle, Chantal, et al
Cabinet Armengaud Aîné
3, Avenue Bugeaud
75116 Paris / FR
[N/P]
Former [2008/52]Peaucelle, Chantal, et al
Cabinet Armengaud Aîné 3, Avenue Bugeaud
75116 Paris / FR
Application number, filing date07734913.205.04.2007
[2008/52]
WO2007IB01774
Priority number, dateEP2006029056306.04.2006         Original published format: EP 06290563
US20060789575P06.04.2006         Original published format: US 789575 P
[2008/52]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008004058
Date:10.01.2008
Language:EN
[2008/02]
Type: A2 Application without search report 
No.:EP2004156
Date:24.12.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 10.01.2008 takes the place of the publication of the European patent application.
[2008/52]
Type: B1 Patent specification 
No.:EP2004156
Date:26.01.2011
Language:EN
[2011/04]
Search report(s)International search report - published on:EP12.02.2009
ClassificationIPC:A61K31/7115, A61K31/41, A61K31/42, A61K31/425, A61P31/00, A61P35/00
[2009/16]
CPC:
A61K48/0025 (EP,US); A61K48/00 (EP,KR,US); A61K31/40 (KR);
A61K31/4164 (EP,US); A61K31/4184 (EP,US); A61K31/7088 (EP,US);
A61K48/0033 (EP,US); A61K9/1271 (EP,US); A61P31/00 (EP);
A61P31/12 (EP); A61P33/00 (EP); A61P35/00 (EP);
C12N15/88 (EP,US) (-)
Former IPC [2008/52]A61K31/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/52]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:ZUSAMMENSETZUNGEN ZUR TRANSFEKTION VON GEN-SILENCING-AKTIVEN OLIGONUKLEOTIDEN UND DEREN BIOLOGISCHE UND THERAPEUTISCHE ANWENDUNGEN[2008/52]
English:COMPOSITIONS FOR TRANSFECTION OF OLIGONUCLEOTIDES ACTIVE FOR GENE SILENCING AND THEIR BIOLOGICAL AND THERAPEUTICAL APPLICATIONS[2008/52]
French:COMPOSITIONS DE TRANSFECTION D'OLIGONUCLÉOTIDES ACTIFS DANS LE BLOCAGE DES GÈNES, ET APPLICATIONS BIOLOGIQUES ET THÉRAPEUTIQUES DE CELLES-CI[2008/52]
Entry into regional phase16.10.2008National basic fee paid 
16.10.2008Designation fee(s) paid 
16.10.2008Examination fee paid 
Examination procedure16.10.2008Examination requested  [2008/52]
29.05.2009Despatch of a communication from the examining division (Time limit: M06)
08.12.2009Reply to a communication from the examining division
12.03.2010Communication of intention to grant the patent
09.07.2010Fee for grant paid
09.07.2010Fee for publishing/printing paid
Opposition(s)27.10.2011No opposition filed within time limit [2012/01]
Fees paidRenewal fee
23.04.2009Renewal fee patent year 03
13.03.2010Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY26.01.2011
CZ26.01.2011
EE26.01.2011
HU26.01.2011
LT26.01.2011
LV26.01.2011
MT26.01.2011
PL26.01.2011
RO26.01.2011
SI26.01.2011
SK26.01.2011
TR26.01.2011
BG26.04.2011
GR27.04.2011
IS26.05.2011
PT26.05.2011
[2013/45]
Former [2013/44]CY26.01.2011
CZ26.01.2011
EE26.01.2011
LT26.01.2011
LV26.01.2011
MT26.01.2011
PL26.01.2011
RO26.01.2011
SI26.01.2011
SK26.01.2011
TR26.01.2011
BG26.04.2011
GR27.04.2011
IS26.05.2011
PT26.05.2011
Former [2012/05]CY26.01.2011
CZ26.01.2011
EE26.01.2011
LT26.01.2011
LV26.01.2011
MT26.01.2011
PL26.01.2011
RO26.01.2011
SI26.01.2011
SK26.01.2011
BG26.04.2011
GR27.04.2011
IS26.05.2011
PT26.05.2011
Former [2011/49]CY26.01.2011
CZ26.01.2011
EE26.01.2011
LT26.01.2011
LV26.01.2011
PL26.01.2011
RO26.01.2011
SI26.01.2011
SK26.01.2011
BG26.04.2011
GR27.04.2011
IS26.05.2011
PT26.05.2011
Former [2011/37]CY26.01.2011
LT26.01.2011
LV26.01.2011
PL26.01.2011
SI26.01.2011
BG26.04.2011
GR27.04.2011
IS26.05.2011
PT26.05.2011
Former [2011/36]LT26.01.2011
LV26.01.2011
PL26.01.2011
GR27.04.2011
IS26.05.2011
PT26.05.2011
Cited inInternational search[Y]WO9845317  (GENZYME CORP [US]) [Y] 1-30 * the whole document *;
 [Y]WO9958152  (UNIV FLORIDA [US]) [Y] 1-30 * the whole document *;
 [Y]US6071890  (SCHEULE RONALD K [US], et al) [Y] 1-30 * the whole document *;
 [A]WO0172280  (BIOSPHERE MEDICAL INC [US], et al) [A] 1-28* the whole document *;
 [Y]US2003044983  (HERWEIJER HANS [US], et al) [Y] 1-30 * the whole document *;
 [YP]  - LV ET AL, "Toxicity of cationic lipids and cationic polymers in gene delivery", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, (20060810), vol. 114, no. 1, ISSN 0168-3659, pages 100 - 109, XP005586193 [YP] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.jconrel.2006.04.014
 [Y]  - HYVONEN Z ET AL, "Novel cationic amphiphilic 1,4-dihydropyridine derivatives for DNA delivery", BIOCHIMICA ET BIOPHYSICA ACTA. BIOMEMBRANES, AMSTERDAM, NL, (20001220), vol. 1509, no. 1-2, ISSN 0005-2736, pages 451 - 466, XP004273389 [Y] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0005-2736(00)00327-8
 [Y]  - FISCHER A ET AL, "Synthesis of new amphiphilic cationic block copolymers and study of their behaviour in aqueous medium as regards hydrophobic microdomain formation", POLYMER, ELSEVIER SCIENCE PUBLISHERS B.V, GB, (20010201), vol. 42, no. 4, ISSN 0032-3861, pages 1441 - 1448, XP004219060 [Y] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0032-3861(00)00493-6
 [A]  - PLANK C ET AL, "Branched cationic peptides for gene delivery : role of type and number of cationic residues in formation and in vitro activity of DNA polyplexes", HUMAN GENE THERAPY, MARY ANN LIEBERT, NEW YORK ,NY, US, (19990120), vol. 10, no. 2, ISSN 1043-0342, pages 319 - 332, XP002349695 [A] 1-28 * the whole document *

DOI:   http://dx.doi.org/10.1089/10430349950019101
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.